This inventor holds 7 USPTO granted patents and 3 published patent applications and 6 EPO patents. Top assignees: Topivert Pharma Limited, Respivert Limited, Step Pharma S.a.s.. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 26 
2 out of 63 
2 out of 7 Years Active: 2017-2025
Title: Geraint Jones: Innovator in Neurological and Psychiatric Treatments
Introduction
Geraint Jones is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurological and psychiatric disorders. With a total of seven patents to his name, Jones has established himself as a key figure in medical innovation.
Latest Patents
Among his latest patents are the Oxexin 1 receptor antagonists, which involve novel compounds designed to treat, prevent, ameliorate, control, or reduce the risk of neurological or psychiatric disorders associated with orexin receptors. Additionally, he has developed aminothiazole compounds as inhibitors of CTPS1, showcasing his expertise in creating effective pharmaceutical solutions.
Career Highlights
Throughout his career, Geraint Jones has worked with several prominent companies, including Topivert Pharma Limited and Respivert Limited. His work in these organizations has allowed him to focus on innovative treatments that address critical health issues.
Collaborations
Jones has collaborated with notable professionals in his field, including Thomas Matthew Baker and Matthew Colin Thor Fyfe. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Geraint Jones is a distinguished inventor whose work has the potential to significantly impact the treatment of neurological and psychiatric disorders. His innovative patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile